Aluminum Adjuvants-'Back to the Future'.

Area of Science:

• Vaccinology
• Immunology
• Materials Science

Background:

• Aluminum-based adjuvants are extensively used in vaccines owing to their established safety, cost-effectiveness, and regulatory acceptance.
• Their flexibility allows for liquid formulations with long shelf lives, making them a cornerstone of current and future vaccine development.

Purpose of the Study:

• To review aluminum salts used in vaccines and their preparation methods.
• To highlight analytical challenges in characterizing complex vaccine formulations, especially those with multiple antigens.
• To explore the use of aluminum adjuvants with Toll-like receptor (TLR) agonists for enhanced vaccine efficacy.

Main Methods:

• Literature review of aluminum salts in vaccine formulations.
• Discussion of preparation techniques for aluminum adjuvants.
• Analysis of challenges in characterizing multi-component vaccine formulations.
• Examination of strategies for co-delivering TLR agonists with aluminum adjuvants.

Main Results:

• Aluminum adjuvants are versatile and widely accepted but often considered 'weak' on their own.
• Combining aluminum adjuvants with immune potentiators, such as TLR agonists, improves their performance.
• This approach has led to improved vaccines for HPV, HBV, and COVID-19.

Conclusions:

• Aluminum adjuvants remain vital, with ongoing research focused on enhancing their potency.
• Co-delivery of TLR agonists with aluminum represents a promising strategy for next-generation vaccines.
• Addressing analytical challenges is key to developing well-characterized, high-performance aluminum-adjuvanted vaccines.